Annette Colin

Annette is currently the CFO at Biotage (BIOT (STO)) and has more than 30 years of experience in different functions within finance and management in executive positions as CEO, CFO, COO, Group Financial Controller, and Tax Manager, including 14 years in Life Science. Annette Colin has been part of fast-growing companies and organizations and has long experience in building strategic plans, leadership development, and streamlining infrastructure. She worked with both Venture Capital and Private Equity owners, but the majority were in listed companies. Most recent assignments include Annexin Pharmaceuticals AB (publ) Observe Medical International (publ), Stille AB (publ), Lindab International AB (publ), Perbio Science AB (publ), and EY. She has also experienced as an investor and from board assignments. Annette has education in Business Administration, marketing, organizational-learn, and law at Lund University, Sweden.